Global Allergy Immunotherapy Market Size is valued at USD 1.9 Billion in 2024 and is predicted to reach USD 4.3 Billion by the year 2034 at an 8.5% CAGR during the forecast period for 2025-2034
Key Industry Insights & Findings from the Report:
The COVID-19 pandemic is a rare health threat that is hurting people's lives, businesses, industries, and communities all across the world. Many businesses are still concentrating their research and development efforts on the creation of medicines against COVID-19 even if regulatory authorities have already approved their vaccines against the SARS-CoV-2 virus.
Healthcare providers continued to provide treatments or treatment advice during the pandemic since allergy patients require ongoing therapy and medication supply. For instance, it is advised that allergic patients who have asthma, rhinitis, atopic dermatitis, or chronic urticaria continue to receive maintenance therapy in a well-controlled manner during the pandemic, per the study titled "Management of Allergic Patients During the COVID-19 Pandemic in Asia" published in February 2021.
The key factors expediting the market's growth are the rising prevalence of different types of allergies and the introduction of innovative sublingual immunotherapies in emerging nations. One of the main drivers of the market is the rising burden of different forms of allergies. For instance, more than 50.0 million Americans suffer from an allergy of some sort each year, according to a journal article published by SingleCare in January 2022.
Additionally, it stated that allergies are the sixth most common chronic ailment in the US. According to a poll performed by SingleCare in 2021, 82.0% of respondents with allergies said their allergies have an impact on their quality of life in the US. In addition, the survey's findings revealed that 14.0% of respondents had experienced hospitalizations as a result of an allergic response. Because of this, it is projected that there will be an increase in the demand for allergy immunotherapy during the course of the projection period. But during the course of the projection period, it is anticipated that a lack of knowledge regarding allergies and treatments will restrain market expansion.
The Allergy Immunotherapy market is segmented based on treatment type, allergy type, and distribution channel. Based on treatment type, the market is divided into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), Tablets, and Drops. The allergy type segment includes Allergic rhinitis, Allergic asthma, and Others. Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy are the segments by distribution channel.
The main factor driving the segment is subcutaneous immunotherapy's (SCIT) excellent efficacy and cost-effectiveness. Subcutaneous immunotherapy (SCIT) is much more effective than sublingual immunotherapy (SLIT) drops or tablets in controlling symptoms of allergic rhinitis, according to a study titled "Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison" published in August 2021. Sublingual immunotherapy's (SLIT) excellent efficacy thus suggests that the product's demand would likely rise throughout the projected period, driving the segment's expansion.
Due to the increase in patients seeking treatment for allergic illnesses, the hospital pharmacy segment had the lion's share. For monitoring and treating any negative responses, allergy injections are typically administered at medical facilities or doctor's offices.
Over the forecast period, North America is anticipated to dominate the market for allergy immunotherapy as a whole. Increased allergy cases and greater public awareness of allergy therapy are among the reasons contributing to the development. For instance, according to research released in May 2022 by the International Food Information Council, around 32.0 million Americans have reported having a food allergy, and every year, roughly 200,000 people seek emergency medical attention because of a food allergy. It also stated that food allergies were frequent in children, with one in every 13 kids in the US receiving a diagnosis, and that 40.0% of kids with food allergies were also allergic to other foods. It is anticipated that situations like these would increase the need for allergy immunotherapy in this area.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1.9 Billion |
|
Revenue Forecast In 2034 |
USD 4.3 Billion |
|
Growth Rate CAGR |
CAGR of 8.5% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Treatment Type, Allergy Type, And Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
ASIT Biotech; Circassia; Mylan N.V.; Adamis Pharmaceuticals Corporation; Merck KGaA; Stallergenes Greer plc; Allergy Therapeutics; ALK-Abelló A/S; DESENTUM OY; HAL Allergy B.V.; HollisterStier Allergy; LETIPharma; DBV Technologies SA. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Allergy Immunotherapy Market Snapshot
Chapter 4. Global Allergy Immunotherapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Industry
Chapter 5. Market Segmentation 1: By Treatment Type Estimates & Trend Analysis
5.1. By Treatment Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Treatment Type:
5.2.1. Subcutaneous Immunotherapy (SCIT)
5.2.2. Sublingual Immunotherapy (SLIT)
5.2.2.1. Tablets
5.2.2.2. Drops
Chapter 6. Market Segmentation 2: By Allergy Type Estimates & Trend Analysis
6.1. By Treatment Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Allergy Type:
6.2.1. Allergic rhinitis
6.2.2. Allergic asthma
6.2.3. Others
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. By Treatment Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
7.2.1. Hospital Pharmacy
7.2.2. Retail Pharmacy
7.2.3. Online Pharmacy
Chapter 8. Allergy Immunotherapy Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Treatment Type, 2021-2034
8.1.2. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.1.3. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.1.4. North America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.2.2. Europe Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.2.3. Europe Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.2.4. Europe Allergy Immunotherapy Market revenue (US$ Million) by country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.3.2. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.3.3. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.3.4. Asia Pacific Allergy Immunotherapy Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, 2021-2034
8.4.2. Latin America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.4.3. Latin America Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.4.4. Latin America Allergy Immunotherapy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) by By Treatment Type, (US$ Million)
8.5.2. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Allergy Type, 2021-2034
8.5.3. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.5.4. Middle East & Africa Allergy Immunotherapy Market revenue (US$ Million) by country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ASIT Biotech
9.2.2. Circassia
9.2.3. Mylan N.V.
9.2.4. Adamis Pharmaceuticals Corporation
9.2.5. Merck KGaA
9.2.6. Stallergenes Greer plc
9.2.7. Allergy Therapeutics
9.2.8. ALK-Abelló A/S
9.2.9. DESENTUM OY
9.2.10. HAL Allergy B.V.
9.2.11. HollisterStier Allergy
9.2.12. LETIPharma
9.2.13. DBV Technologies SA
Allergy Immunotherapy Market By Treatment Type-
Allergy Immunotherapy Market By Allergy Type-
Allergy Immunotherapy Market By Distribution Channel-
Allergy Immunotherapy Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
